Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Celgene slumps as Bristol-Myers shareholder resists merger

Shares of Celgene Corp. dived 8 percent after a major shareholder in Bristol-Myers Squibb Co. came out against a $74 billion merger that would be the pharmaceutical world’s largest-ever takeover.

Read More »

Mylan shares sink due to bleak profit outlook for 2019

Mylan NV shares slid 10 percent after the generic drug maker predicted poor 2019 earnings that led some Wall Street analysts to wonder if the company’s finances would worsen further.

Read More »

Sarepta to buy Myonexus in gene therapy push

Sarepta Therapeutics will buy privately held gene therapy company Myonexus Therapeutics for $165 million, moving deeper into an emerging and lucrative field within the biotech sector.

Read More »

Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals

Bausch Health Companies Inc. was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of approximately $195 million and the assumption of certain assumed liabilities, pursuant to the terms of the stalking horse asset purchase agreement previously entered into.

Read More »

U.S. House Democrats introduce sweeping ‘Medicare for All’ bill

Democrats in the U.S. House of Representatives unveiled an ambitious proposal to move all Americans into the government’s Medicare health insurance program.

Read More »

Immunomedics’ CEO and President Steps Down

Morris Plains, N.J.-based Immunomedics announced that the company’s president, chief executive officer and board member, Michael Pehl, was stepping down for personal reasons.

Read More »

Amicus Therapeutics to Hire 200 Researchers at New Gene Therapy Center in Philadelphia

Amicus Therapeutics – with headquarters in Cranbury, New Jersey – announced that the company is launching a Global Research and Gene Therapy Center of Excellence in Philadelphia.

Read More »

Senators tell drug company executives pricing is ‘morally repugnant’

U.S. Senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on the rising costs of prescription medicines.

Read More »

Benchworks Announces Formation of BW Health Group

Benchworks Inc. announced the formation of BW Health Group, an integrated healthcare company led by Tom McDonnell.

Read More »

EVERSANA appoints experienced life science industry leaders to executive management team

EVERSANA announced three appointments to the company’s executive leadership team.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom